[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Pages 81947-81948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-33396]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory Committee), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463) the Centers for Disease Control and
Prevention (CDC), announces the following meetings of the
aforementioned committee:
Committee Public Meeting Times and Dates: (All times are Eastern
Standard Time).
Teleconference Meeting: 1 p.m.-5 p.m., January 24, 2012.
This meeting is available via the USA toll-free, dial-in number: 1-
(888) 801-1939. To be automatically connected to the meeting, you will
need to enter the following participant code: 62062756.
Public Comment Times and Date: 4 p.m.-4:45 p.m., January 24, 2012.
Please note that the public comment period ends at the time
indicated or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name by mail, facsimile, email, or telephone, as given
below. Each commenter will be provided up to five minutes for comment.
A limited number of time slots are available and will be assigned on a
first come-first served basis. Written comments will also be accepted
from those unable to attend the public session.
Status: Open to the public, limited only by the number of telephone
lines. The conference line will accommodate up to 100 callers;
therefore it is suggested that those interested in calling in to listen
to the committee meeting share a line when possible.
Background: The Advisory Committee was established by Public Law
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010,
Title XXXIII of the Public Health Service Act), enacted on January 2,
2011 and codified at 42 U.S.C. 300mm-300mm-61.
Purpose: The purpose of the Advisory Committee is to review
scientific and medical evidence and to make recommendations to the
World Trade Center (WTC) Program Administrator regarding additional WTC
Health Program eligibility criteria and potential additions to the list
of covered WTC-related health conditions. Title XXXIII of the Public
Health Service Act established within the Department of Health and
Human Services (HHS), the World Trade Center (WTC) Health Program, to
be administered by the WTC Program Administrator. The WTC Health
Program provides: (1) Medical monitoring and treatment benefits to
eligible emergency responders and recovery and cleanup workers
(including those who are Federal employees) who responded to the
September 11, 2011, terrorist attacks, and (2) initial health
evaluation, monitoring, and treatment benefits to residents and other
building occupants and area workers in New York City who were directly
impacted and adversely affected by such attacks (``survivors'').
Certain specific activities of the WTC Program Administrator are
reserved to the Secretary, HHS, to delegate at her discretion; other
WTC Program Administrator duties not explicitly reserved to the
Secretary, HHS, are assigned to the Director, NIOSH. The administration
of the Advisory Committee established under Section 300mm-1(a) is left
to the Director of NIOSH in his role as WTC Program Administrator. CDC
and NIOSH provide funding, staffing, and administrative support
services for the Advisory Committee. The charter was issued on May 12,
2011, and will expire on May 12, 2013.
Matters To Be Discussed: The agenda for the Advisory Committee meeting
includes: WTC Health Program Research Priorities and the petition to
add cancer to the list of WTC Health Program covered conditions. The
agenda is subject to change as priorities dictate. In the event an
individual cannot attend, written comments may be submitted. The
comments should be limited to two pages and submitted to the contact
person below by January 18, 2012. Efforts will be made to provide the
two-page written comments received by the deadline below to the
committee members before the meeting. Comments in excess of two pages
will be made publicly available at the NIOSH docket (http://www.cdc.gov/niosh/docket/archive/docket248.html).
Public Comment Sign-Up and Submissions to the Docket: To sign up to
provide public comments or to submit comments to the docket, send
information to the NIOSH Docket Office by one of the following means:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533-8285.
Email: [email protected].
Telephone: (513) 533-8611.
Submissions to the docket should reference docket 248.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to NIOSH Docket 248
within 60 days after the meeting. If a person making a comment gives
his or her name, no attempt will be made to redact that name. NIOSH
will take reasonable steps to ensure that individuals making public
comments are aware of the fact that their comments (including their
name, if provided) will appear in a transcript of the meeting posted on
a public Web site. Such reasonable steps include: (a) A statement read
at the start of the meeting stating that transcripts will be posted and
names of speakers will not be redacted; and (b) A printed copy of the
statement mentioned in (a) above will be displayed on the table where
individuals sign up to make public comments. If individuals in making a
statement reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and if
deemed appropriate, will redact such information. Disclosures of
information concerning third party medical information will be
redacted.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway,
MailStop R-45, Cincinnati, Ohio 45226, Telephone: 1 (888) 982-4748;
email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the
[[Page 81948]]
Centers for Disease Control and Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: December 22, 2011.
Ronald Ergle,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2011-33396 Filed 12-28-11; 8:45 am]
BILLING CODE 4163-18-P